Switzerland

News Switzerland

• Merck Announces Merck Serono Implementation Plans for Its Efficiency Program in Switzerland

  Merck announced the efficiency measures it plans to take related to Merck Serono’s operations in Switzerland as part of the comprehensive transformation program announced by the company in February. Merck’s transformation program is focused on addressing unprecedented market shifts, increasing compe more

• Bench International Expands Presence in Europe with Opening of Offices in Switzerland

  Bench International, a global executive recruiting and consulting firm serving the life sciences industry, recently opened new offices in Geneva and Zurich, Switzerland consistent with its global growth strategy. The offices are strategically placed to serve Switzerland's main linguistic regions. Th more

• Novartis drug Votubia approved as first medication in Switzerland for SEGA, a benign brain tumor associated with tuberous sclerosis

  Swissmedic has approved Votubia® (everolimus) tablets for the treatment of patients 3 years of age and older, with subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis (TS), for whom surgery is not a suitable option. Votubia is the first medication approved in Switzerland to more

White papers Switzerland

• DKSH Performance Materials: Introduction of new program to source products
  

  Even under pressure to reduce costs, effective cooperation and hard work will always find a way to fulfill expectations. Most global players in the pharmaceutical industry are facing dramatic changes: blockbuster products launched in the 1990s will lose their patents over the next few years and face competition which will threaten their steady earnings more

• Efficient Transfection of 293T Cell Line with Lentiviral Vectors Using FuGENE® HD Transfection Reagent
  

  Lentiviral vectors have become a powerful tool for gene transfer and genetic manipulation in research. Efficiency of the transfection reagent is most critical to getting a high-titer lentiviral recombinant virus. Here, we show that FuGENE® HD Transfection Reagent can be used to transfect 293T cells with lentiviral vectors with high efficiency. more

• Transfecting Mouse Fibroblast NIH 3T3 Cells with Lipid Reagents - A Comparative Study
  

  Prior to the advent of transfection lipids, mouse fibroblast NIH 3T3 cells were essentially untransfectable and other methods such as retroviral gene delivery had to be employed to circumvent this problem. Although retroviruses can be used for transgene expression in 100% of cells, the expression is often low. Additionally, NIH 3T3 cells are traditionally used for cellular transformation studies, and creating oncogenic retroviruses is not ideal due to bio-safety concerns. Recently, lentivruses have been used for high gene expression in cells (up to 100%). However, this method causes even greater bio-safety concerns and requires updating culture facilities to bio-safety level 2+, resulting in a costly and time-consuming procedure. more

Publications Switzerland

• Phylogeny and biogeography of an uncultured clade of Snow Chytrids

  Summary Numerous studies have shown that snow can contain a diverse array of algae known as “snow algae”. Some reports also indicate that parasites of algae (e.g. chytrids) are also found in snow, but efforts to phylogenetically identify “snow chytrids” have not been successful. We used culture‐ more

• HIV Infection Disrupts the Sympatric Host–Pathogen Relationship in Human Tuberculosis

  by Lukas Fenner, Matthias Egger, Thomas Bodmer, Hansjakob Furrer, Marie Ballif, Manuel Battegay, Peter Helbling, Jan Fehr, Thomas Gsponer, Hans L. Rieder, Marcel Zwahlen, Matthias Hoffmann, Enos Bernasconi, Matthias Cavassini, Alexandra Calmy, Marisa Dolina, Reno Frei, Jean-Paul Janssens, Sonia Bor more

• Molecular epidemiology of methicillin‐resistant Staphylococcus aureus in Switzerland: sampling only invasive isolates does not allow a representative description of the local d ...

  Abstract We conducted a molecular study of MRSA isolated in Swiss hospitals, including the first five consecutive isolates recovered from blood cultures and the first ten isolates recovered from other sites in newly identified carriers. Among 73 MRSA isolates, 44 different double locus sequence more

Market studies Switzerland

• Switzerland Endoscopy Devices Investment Opportunities, Analysis and Forecasts to 2017

  Introduction ”Switzerland Endoscopy Devices Investment Opportunities, Analysis and Forecasts to 2017”, a new report by Global Markets Direct, provides key market data on the Switzerland Endoscopy Devices market. The report provides value (USD million), volume (units) and average price (USD) data f more

• Switzerland Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2018

  Introduction Global Markets Direct’s new report, “Switzerland Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2018” provides key market data on the Switzerland Diabetes Care Devices market. The report provides value (USD million), volume (units) and average price (USD) da more

• Switzerland Surgical Equipment Investment Opportunities, Analysis and Forecasts to 2018

  Introduction ”Switzerland Surgical Equipment Investment Opportunities, Analysis and Forecasts to 2018”, a new report by Global Markets Direct, provides key market data on the Switzerland Surgical Equipment market. The report provides value (USD million), volume (units) and average price (USD) data more

Websites Switzerland